Showing results (2421-2430 of 3,032) with videos related to
Sort By:
Pageof 304
Clinical Kidney Journal|April 4, 2022
Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD studyPamela Kushner, Emily Peach, Eric Wittbrodt, et al.Clinical Kidney Journal|April 4, 2022
How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studiesToby Humphrey, Mogamat Razeen Davids, Mogamat-Yazied Chothia, et al.Clinical Kidney Journal|April 4, 2022
Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: results of the HOME ALONE studyInsa E Emrich, Anja L Scheuer, Kyrill S Rogacev, et al.Clinical Kidney Journal|February 24, 2022
Renin-angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney diseaseMarieta P Theodorakopoulou, Maria-Eleni Alexandrou, Afroditi K Boutou, et al.Clinical Kidney Journal|February 25, 2022
RICORS2040: the need for collaborative research in chronic kidney diseaseAlberto Ortiz, Clinical Kidney Journal|February 25, 2022
The Latin American Dialysis and Renal Transplantation Registry: report 2019Rosario Luxardo, Laura Ceretta, María González-Bedat, et al.Clinical Kidney Journal|February 25, 2022
CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcomeNeus Roca, Elias Jatem, Anabel Abo, et al.Clinical Kidney Journal|February 25, 2022
Application of the Clinical Frailty Score and body composition and upper arm strength in haemodialysis patientsAndrew DavenportClinical Kidney Journal|March 9, 2022
Can kidney parenchyma metabolites serve as prognostic biomarkers for long-term kidney function after nephrectomy for renal cell carcinoma? A preliminary studyBarak Rosenzweig, Pedro Recabal, Caroline Gluck, et al.Clinical Kidney Journal|March 9, 2022
Idarucizumab for the treatment of dabigatran-related nephropathyAmmar Alsamarrai, Nicola Eaddy, Elizabeth CurryPageof 304